ArticleNeoplasia (New York, N.Y.)2012

MicroRNA expression profiling of peripheral blood samples predicts resistance to first-line sunitinib in advanced renal cell carcinoma patients.

Angelo Gámez-Pozo et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.